中医临床研究
中醫臨床研究
중의림상연구
CLINICAL JOURNAL OF CHINESE MEDICINE
2013年
22期
12-13
,共2页
心力衰竭%慢性%室性早搏%频发%稳心颗粒
心力衰竭%慢性%室性早搏%頻髮%穩心顆粒
심력쇠갈%만성%실성조박%빈발%은심과립
Heart failure%Chronic%Premature ventricular contractions%Frequent%Wenxin granule
目的:观察稳心颗粒对慢性心衰合并频发室性早搏患者的室早疗效及症状改善的影响。方法:将入选40例患者随机分为治疗组和对照组,两组患者各为20例。治疗组在常规治疗的基础上加用稳心颗粒口服治疗,对照组则仅给予常规药物治疗,两组患者的疗程均为8周。观察两组患者治疗前后24h动态心电图的结果,并详细记录患者疗前疗后症状的变化。结果:治疗组室早疗效优于对照组,差异有统计学意义(P<0.05)。两组治疗前后临床症状综合积分较疗前均有改善,治疗组疗效优于对照组(P<0.05)。结论:稳心颗粒用于慢性心衰并频发室早的治疗,可明显减少患者的室早总数,并有效改善患者症状,提高患者的生存质量。
目的:觀察穩心顆粒對慢性心衰閤併頻髮室性早搏患者的室早療效及癥狀改善的影響。方法:將入選40例患者隨機分為治療組和對照組,兩組患者各為20例。治療組在常規治療的基礎上加用穩心顆粒口服治療,對照組則僅給予常規藥物治療,兩組患者的療程均為8週。觀察兩組患者治療前後24h動態心電圖的結果,併詳細記錄患者療前療後癥狀的變化。結果:治療組室早療效優于對照組,差異有統計學意義(P<0.05)。兩組治療前後臨床癥狀綜閤積分較療前均有改善,治療組療效優于對照組(P<0.05)。結論:穩心顆粒用于慢性心衰併頻髮室早的治療,可明顯減少患者的室早總數,併有效改善患者癥狀,提高患者的生存質量。
목적:관찰은심과립대만성심쇠합병빈발실성조박환자적실조료효급증상개선적영향。방법:장입선40례환자수궤분위치료조화대조조,량조환자각위20례。치료조재상규치료적기출상가용은심과립구복치료,대조조칙부급여상규약물치료,량조환자적료정균위8주。관찰량조환자치료전후24h동태심전도적결과,병상세기록환자료전료후증상적변화。결과:치료조실조료효우우대조조,차이유통계학의의(P<0.05)。량조치료전후림상증상종합적분교료전균유개선,치료조료효우우대조조(P<0.05)。결론:은심과립용우만성심쇠병빈발실조적치료,가명현감소환자적실조총수,병유효개선환자증상,제고환자적생존질량。
Objective:To observe the effect and symptoms improvement of Wenxin granule on treating chronic heart failure and frequent premature ventricular contractions. Methods:40 patients were selected randomly divided into treated group and control group, 20 cases for each. The control group was given the normal therapy, while the treated was given the Wenxin granule more. two groups of patients with a course of eight weeks. Observed two groups of patients before and after treatment 24-hour ambulatory electrocardiogram results and detailed records of the patient changes in symptoms before and after treatment. Results:Efficacy of the treated group was better than the control group, the difference was statistically significant (P<0.05). The clinical symptoms before and after treatment of the treated group was higher than that in the control (P<0.05). Conclusion:Wenxin granule for chronic heart failure and frequent ventricular premature treatment can significantly reduce the total number of patients with PVCs, and effectively improve symptoms and improve the patient’s quality of life.